Pre-Open Stock Movers 08/14: (TFFP) (DDS) (RKT) Higher; (PAYS) (EQ) (IQ) Lower (more...)

Pre-Open Stock Movers:

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) 23.4% HIGHER; announced that it has entered into a worldwide exclusive licensing agreement with UNION therapeutics A/S (UNION) for its TFF technology used in combination with niclosamide.

Paysign, Inc. (NASDAQ: PAYS) 18% LOWER; reports Q2 results

Co-Diagnostics (NASDAQ: CODX) 16.6% LOWER; reported Q2 EPS of $0.43, $0.16 worse than the analyst estimate of $0.59. Revenue for the quarter came in at $24.04 million versus the consensus estimate of $26.45 million.

Equillium, Inc. (Nasdaq: EQ) 16% LOWER; announced that it intends to offer and sell shares of its common stock in an underwritten registered public offering

Dillard's (NYSE: DDS) 15.4% HIGHER; reported Q2 EPS of ($0.37), $4.17 better than the analyst estimate of ($4.54). Revenue for the quarter came in at $919 million versus the consensus estimate of $1.01 billion.

Blink Charging (NASDAQ: BLNK) 13% HIGHER; reported Q2 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $2.9 million versus the consensus estimate of $1.23 million.

iQIYI (NASDAQ: IQ) 11.2% LOWER; reported Q2 EPS of ($0.28), $0.21 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $1 billion versus the consensus estimate of $1.05 billion. SEC investigation.

Purple Innovation (NASDAQ: PRPL) 10.4% LOWER; reported Q2 EPS of ($0.11), $0.30 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $165.1 million versus the consensus estimate of $175.88 million.

Optinose (NASDAQ: OPTN) 10% LOWER; announced the commencement of a proposed underwritten public offering of shares of its common stock. All of the shares of common stock will be offered by Optinose. Optinose expects to grant the underwriter a 30-day option to purchase up to an additional 15% of the total number of shares of common stock.

Farfetch Limited (NYSE: FTCH) 9.6% HIGHER; reported Q2 EPS of ($0.20), $0.15 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $364.7 million versus the consensus estimate of $326.92 million.

Rocket Companies, Inc. (NYSE: RKT) 8.3% HIGHER; announced preliminary and unaudited results for the second quarter ended June 30, 2020. Closed loan origination volume of $72.3 billion increased 40% compared to the first quarter of 2020 and 126% compared to the second quarter of 2019; Total net revenue of $5.0 billion increased 269% compared to the first quarter of 2020 and 437% compared to the second quarter of 2019

Marathon Patent Group, Inc. (NASDAQ: MARA) 7.6% HIGHER; announced that it has entered into a Long Term Purchase Contract with Bitmain for the purchase of 10,500 next generation Antminer S-19 Pro ASIC Miners.

Baidu.com (NASDAQ: BIDU) 7.5% LOWER; reported Q2 EPS of $1.46, $0.08 better than the analyst estimate of $1.38. Revenue for the quarter came in at $3.69 billion versus the consensus estimate of $3.7 billion. Baidu.com sees Q3 2020 revenue of $3.7-4.1 billion, versus the consensus of $3.97 billion.

Novavax, Inc. (Nasdaq: NVAX) 7.5% HIGHER; signed a Heads of Terms (Term Sheet) with the Government of the United Kingdom (UK) for the purchase of 60 million doses of NVX-CoV2373, Novavax COVID-19 vaccine, and a Phase 3 clinical trial to assess the efficacy of the vaccine in the UK population. Novavax will also expand its collaboration with FUJIFILM Diosynth Biotechnologies, which will manufacture the antigen component of NVX-CoV2373 from its Billingham, Stockton-on-Tees site in the UK, in addition to its sites in North Carolina and Texas in the United States. The FUJIFILM Diosynth Biotechnologies site in the UK is expected to produce up to 180 million doses annually, which further boosts the global supply of NVX-CoV2373 for additional markets.

DraftKings (NASDAQ: DKNG) 5.6% LOWER; reported Q2 EPS of ($0.55), versus ($0.15) reported last year. Revenue for the quarter came in at $70.93 million, versus $57.39 million reported last year.

Precigen, Inc. (NASDAQ: PGEN) 4.6% HIGHER; sees insider buying

Applied Materials (NASDAQ: AMAT) 4.2% HIGHER; reported Q3 EPS of $1.06, $0.11 better than the analyst estimate of $0.95. Revenue for the quarter came in at $4.4 billion versus the consensus estimate of $4.18 billion. Applied Materials sees Q4 2020 EPS of $1.11-$1.23, versus the consensus of $1.02. Applied Materials sees Q4 2020 revenue of $4.4-4.6 billion, versus the consensus of $4.36 billion.

Tesla, Inc. (NASDAQ: TSLA) 2.7% HIGHER; upgraded at BofA and Morgan Stanley

You May Also Be Interested In

• Soligenix, Inc. (SNGX) Prices $4.75 Million Public Offering
• Korro Bio (KRRO) Announces $70M Placement
• Serve Robotics (SBOT) Prices 10M Share Offering at $4/sh, Uplists to Nasdaq